| Name | Title | Type |
|---|---|---|
| Erich Koch | Ceo | Auditee |
| Kristin Osorio | Shareholder | Auditee |
| Amanda Blodgett | CEO | Auditee |
| Kyla Delgado | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 371165 | 2023 | 2025-10-22 | HOFFMAN STEWART & SCHMIDT PC | $3.58M |
| 342976 | 2022 | 2025-02-18 | Hoffman Stewart & Schmidt PC | $3.88M |
| 302660 | 2021 | 2024-04-04 | Cliftonlarsonallen LLP | $4.30M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 371165 | 2023 | 2025-10-22 | 1161153 | 2023-002 | Material Weakness | Yes | N |
| 371165 | 2023 | 2025-10-22 | 1161152 | 2023-002 | Material Weakness | Yes | N |
| 371165 | 2023 | 2025-10-22 | 1161151 | 2023-002 | Material Weakness | Yes | N |
| 342976 | 2022 | 2025-02-18 | 1100040 | 2022-002 | Significant Deficiency | - | N |
| 342976 | 2022 | 2025-02-18 | 1100039 | 2022-002 | Significant Deficiency | - | N |
| 342976 | 2022 | 2025-02-18 | 1100038 | 2022-002 | Significant Deficiency | - | N |
| 342976 | 2022 | 2025-02-18 | 523598 | 2022-002 | Significant Deficiency | - | N |
| 342976 | 2022 | 2025-02-18 | 523597 | 2022-002 | Significant Deficiency | - | N |
| 342976 | 2022 | 2025-02-18 | 523596 | 2022-002 | Significant Deficiency | - | N |
| 302660 | 2021 | 2024-04-04 | 968760 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 968759 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 968758 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 968757 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 968756 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 968755 | 2021-005 | Material Weakness | - | H |
| 302660 | 2021 | 2024-04-04 | 968754 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 968753 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 968752 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 968751 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 968750 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 968749 | 2021-003 | Material Weakness | - | AB |
| 302660 | 2021 | 2024-04-04 | 392318 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 392317 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 392316 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 392315 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 392314 | 2021-006 | Significant Deficiency | - | B |
| 302660 | 2021 | 2024-04-04 | 392313 | 2021-005 | Material Weakness | - | H |
| 302660 | 2021 | 2024-04-04 | 392312 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 392311 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 392310 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 392309 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 392308 | 2021-004 | Significant Deficiency | - | C |
| 302660 | 2021 | 2024-04-04 | 392307 | 2021-003 | Material Weakness | - | AB |